These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2701363)

  • 1. Private and public autocrine loops in neoplastic cells.
    Browder TM; Dunbar CE; Nienhuis AW
    Cancer Cells; 1989 Sep; 1(1):9-17. PubMed ID: 2701363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
    Rogers SY; Bradbury D; Kozlowski R; Russell NH
    Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual interactions between p53 and growth factors in cancer.
    Asschert JG; Vellenga E; De Jong S; de Vries EG
    Anticancer Res; 1998; 18(3A):1713-25. PubMed ID: 9673395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA clones from autocrine thymic lymphoma cells encode two mitogenic proteins, a serine protease and a truncated T-cell receptor beta-chain.
    Bogenberger J; Haas M
    Oncogene Res; 1988; 3(4):301-12. PubMed ID: 2976140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.
    Shimizu S; Nishikawa Y; Kuroda K; Takagi S; Kozaki K; Hyuga S; Saga S; Matsuyama M
    Cancer Res; 1996 Jul; 56(14):3366-70. PubMed ID: 8764135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active factors in the treatment of periodontal disease.
    Terranova VP
    Curr Opin Periodontol; 1993; ():129-35. PubMed ID: 8401835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor receptors: structure, mechanism, and drug discovery.
    McInnes C; Sykes BD
    Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine secretion of peptide growth factors by tumor cells.
    Todaro GJ
    Natl Cancer Inst Monogr; 1982; 60():139-47. PubMed ID: 6289103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
    Favoni RE; de Cupis A
    Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation-related growth factors and their receptors.
    Bregman MD; Sipes NJ
    Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors.
    Castagnino P; Lorenzi MV; Yeh J; Breckenridge D; Sakata H; Munz B; Werner S; Bottaro DP
    Oncogene; 2000 Feb; 19(5):640-8. PubMed ID: 10698509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine and paracrine roles for growth factors in melanoma.
    Shih IM; Herlyn M
    In Vivo; 1994; 8(1):113-23. PubMed ID: 7519892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
    Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
    Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.